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Introduction
Naive T cells become activated upon encounter with 
peptide antigen on the surface of antigen presenting cells 
in association with MHC molecules and then proliferate 
and differentiate to become effector cells [1, 2]. Most ef-
fectors die, but a minority become long-lived memory 
cells [3]. The surface phenotype changes as CD4+ and 
CD8+ T cells progress from naive to activated effectors 
and memory cells, with the gain of CD25, CD44, and 
CD43 and loss of CD62L (reviewed in [4, 5]). Some ac-
tivated T cells can gain cytotoxic activity and secrete 
cytokines such as IFN-γ and TNF-α [6, 7], while others 
gain the ability to provide B cell help [4, 8, 9]. The actual 
events that regulate these processes are not fully under-
stood, and much of our knowledge of T cell activation 
has been gained from in vitro studies and may not be 
fully applicable in vivo.
Following influenza infection in vivo, both CD8+ and 
CD4+ T cells are activated (reviewed in [10]), and the use 
of tetramers has improved the tracking of antigen-spe-
cific populations but is limited in the early phase of the 
response by the low precursor frequency of responding 
cells [11–13]. Adoptive transfer of antigen-specific lym-
phocytes counters this weakness and has been used to 
monitor the T cell response to viruses such as LCMV 
[14], VSV [15], influenza [16–18], and also responses to 
ovalbumin [19, 20]. The respective roles of CD4+ and 
CD8+ cells during infection by influenza have been in-
vestigated using knockout or depletion approaches [21–
26], but these studies did not examine respective rates of 
activation or division of the CD4+ and CD8+ T cells. The 
analysis of CD4+ and CD8+ T cell responses side by side 
during pathogen infection has not been attempted until 
recently [27, 28].
Previous work from our laboratory showed that Tc1 
and Tc2 effector CD8+ lymphocytes were able to protect 
mice from a lethal influenza infection [16], and we com-
pared the efficacy of protection by naive, effector, and 
memory populations [17]. In previous studies, we trans-
ferred large numbers (5 × 106) of CFSE-labeled naive in-
fluenza-specific TCR transgenic CD4+ from HNT mice 
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Abstract
The activation, localization, phenotypic changes, and function of CFSE-labeled naive influenza-specific CD8+ and CD4+ T cells fol-
lowing influenza infection were examined. Response of adoptively transferred CD8+ T cells was seen earliest in draining lymph 
node. Highly activated cells were found later in the lung, airways, and spleen, were cytolytic, and expressed IFN-γ upon restimu-
lation. Similar amounts of division at early time points, but higher numbers of CD8+ T cells, were detected at 9 and 30 days postin-
fection after cotransfer of CD4+ and CD8+ T cells followed by infection. Transfer of much smaller numbers of CD4+ and CD8+ T 
cells led to more extensive expansion but the same difference in final number between the two cell types. These studies demon-
strate how CD8+ and CD4+ T cells respond to influenza at early time points postinfection and the differential kinetics of antigen-
specific CD4+ and CD8+ T cells.
Keywords: virus infection, T lymphocytes, cellular activation, cellular proliferation, cell surface molecules
Abbreviations: BAL, bronchoalveolar lavage; DLN, draining lymph nodes; NDLN, nondraining lymph nodes; HA, 
hemagglutinin
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and showed that after influenza infection, activated do-
nor cells were detected in the spleen, lung, and bron-
choalveolar lavage (BAL) in large numbers. The phe-
notypic changes increased with each division, and only 
cells that had gone through multiple divisions and ex-
pressed an activated phenotype were found in the lung 
and BAL [18].
Our primary goal here was to document the response 
of CD8+ T cells in response to sublethal influenza infec-
tion and to compare the response of CD4+ and CD8+ T 
cells. We demonstrate, using adoptive transfers of influ-
enza-specific CD8+ and CD4+ T cells that both CD8+ and 
CD4+ T cells were found to divide first in the draining 
lymph nodes (DLN) and were then subsequently found 
in lung, BAL, and spleen. Cotransfer of CD4+ and CD8+ 
T cells demonstrated that the CD8+ T cells expanded 
to and were maintained for 30 days at higher numbers 
than CD4+ T cells. CFSE-monitored division was not sig-
nificantly different in CD8+ T cells compared with CD4+ 
T cells. Adoptive transfer of smaller numbers of CD8+ 
and CD4+ T cells resulted in similar peak numbers of 
cells as with larger transfer doses, confirming that the 
two cell types are regulated differently. Uniquely, adop-
tive transfer allows the analysis of the early phase of the 
response where T cell division and phenotypic change 
can be examined in the DLN and allows manipulation 
of the number of input cells.
Materials and methods
Mice
BALB/c Thy1.1+ (gift from Dr. C. Suhr, Scripps In-
stitute, La Jolla, CA), BALB/c (Thy1.2+) hemaglut-
tinin (HA)-specific clone-4 TCR transgenic (gift from 
Dr. L. Sherman, Scripps Institute), BALB/c HNT CD4+ 
TCR transgenic mice (gift from Dr. D. Lo, Scripps Insti-
tute), (BALB/c HNT × Thy1.1+) F1, and (BALB/c HA × 
Thy1.1+) F1 mice were bred at the Trudeau Institute an-
imal breeding facility. HA clone-4 mice recognize the 
peptide (IYSTVASSL) residues 518-26 from the hemag-
glutinin gene of influenza virus PR8 presented on H2-
Kd [29]. BALB/c HNT mice are CD4+ transgenic mice 
that recognize peptide (HNTNGVTAACSHE), residues 
126-138, from HA in the context of I-Ad [30]. BALB/c 
Thy1.2+ mice were purchased from the Jackson Labora-
tory (Bar Harbor, ME). All animal procedures were done 
in accordance with guidelines from the Institute Animal 
Care and Use Committee (IACUC) at Trudeau Institute.
Cell culture medium
Cells were washed in RPMI with 1% FCS, 1 mM so-
dium pyruvate, 200 U/ml penicillin, 200 μg/ml strep-
tomycin, 0.4 mM glutamine, 0.1 mM nonessential amino 
acid solution (Gibco Invitrogen Corporation, Grand Is-
land, NY). Tissue culture medium (TCM) was wash me-
dia with 5% FCS and 4.5 × 10−5 M 2-mercaptoethanol 
(Sigma, St. Louis, MO). P815 cells for cytotoxicity assays 
were maintained in DMEM with high glucose (Irvine 
Scientific, Santa Ana, CA) supplemented with penicil-
lin/streptomycin and 10% FCS [16].
Cell preparation and adoptive transfer
Single cell suspensions of CD8+ cells were prepared 
from cervical, inguinal, axillary, and brachial lymph 
nodes and spleens from clone-4 TCR transgenic Thy1.2+ 
mice. Cells were purified by positive selection with anti-
CD8α beads using MACS columns according to manu-
facturer’s protocol (Miltenyi Biotech, Auburn, CA) and 
then centrifuged on a four-layer Percoll (Sigma) gradi-
ent to remove activated cells [16]. CD4+ cells were pre-
pared from HNT mice using antibody and complement 
depletion followed by a Percoll gradient [31] or by pos-
itive selection on MACS columns followed by centrifu-
gation on Percoll as for CD8. Naive CD8+ and CD4+ T 
cells were over 90% pure and were not contaminated by 
significant numbers of other T cells or B cells. They ex-
pressed high levels of CD62L, low levels of CD25, and 
intermediate levels of CD44 (data not shown). Cells 
were counted using an ACT10 Coulter counter (Bec-
ton Coulter, Brea, CA) or trypan blue dye exclusion. In-
jected intravenously into the lateral tail vein of BALB/
c Thy1.1+ recipients were 5 × 106 CFSE-labeled Thy1.2+ 
CD8+ cells in 500 μl PBS (Gibco). For cotransfer experi-
ments, 3 × 106 Thy1.2+ HA mixed with 3 × 106 Thy1.2+ 
HNT CFSE-labeled cells in 250 μl PBS were injected into 
Thy1.1+ BALB/c mice. In some experiments, cells from 
HA (Thy1.1+ × 1.2+) F1 or HNT (Thy1.1+ × 1.2+) F1 mice 
were injected into BALB/c Thy1.2+ recipients. No signif-
icant differences were seen between transferring Thy1.2 
into Thy1.1 and Thy1.2 × Thy1.1 into Thy1.2 mice.
CFSE labeling
CFSE (Molecular Probes, Eugene, OR) was stored at 
−20°C in DMSO (Sigma) at a concentration of 10 mM. 
Cells were labeled with a 1/4000 dilution of the stock 
diluted 1:1 with cells at 2 × 107/ml in PBS and incubated 
for 8 min at RT. Cells were then quenched with FBS and 
washed three times with PBS [32].
Influenza virus and infections
Influenza Puerto Rico (PR8) (H1N1) virus (a gift from 
Drs. D. Morgan and L. Sherman) was grown in the al-
lantoic fluid of embryonated hens eggs as described in 
Refs. [18 and 33]. Mice were infected with influenza by 
intranasal inoculation of 50 or 100 μl of virus in PBS. 
A sublethal dose of 15000 EIU (0.5 LD50 determined 
in BALB/c mice) or 6000 EIU (0.2 LD50) was routinely 
given, 16–20 h after adoptive cell transfer. Control mice 
were given 50 μl PBS intranasally.
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Tissue sampling and flow cytometry of surface markers
Mice were sacrificed by exsanguination under deep iso-
fluorane inhalation anesthesia at various time points af-
ter influenza infection, and spleen, the nondraining ax-
illary, and brachial and inguinal lymph nodes (NDLN) 
were taken. Bronchoalveolar lavage (BAL) was col-
lected by washing the airways four times with 0.5 ml 
10 mM EDTA (Sigma) in PBS. Lungs were removed fol-
lowing perfusion with 5 ml PBS via the left ventricle of 
the heart. Finally, the draining mediastinal and para-
thymic draining lymph nodes (DLN) were collected. 
Single cell suspensions were prepared using 70-μm ny-
lon filters (Falcon, Franklin Lakes, NJ). The cells were 
washed and resuspended in FACS buffer [PBS with 2% 
(w/v) BSA (Intergen, Purchase, NY) and 0.1% (w/v) 
sodium azide (Sigma)] then incubated with 1 μg anti-
FcR (clone 2.4G2, produced by Trudeau Institute) fol-
lowed by anti-CD8-PerCP (53-6.7), or anti-CD4-perCP 
(RM4-5) anti-Thy1.2-APC (53-2.1), and one of a number 
of PE-labeled conjugates: anti-CD62L (MEL-14), anti-
CCR5 (C34-3448), anti-CD44 (IM7), anti-CD25 (PC61, 
Caltag, Burlingame, CA), anti-CD43 (1B11), anti-CD69 
(H1-2F3) anti-Vβ8.1/8.2 (MR5-2), and anti-Ly6C (HK1-
4), all obtained from BD Biosciences, San Diego, CA, 
except where noted. Cells were then washed and an-
alyzed on a four-color FACSCalibur (BD Biosciences, 
San Jose, CA) using CellQuest software. Profiles were 
analyzed using FlowJo (Treestar, San Carlos, CA) by 
determining the percentage of CD8+ Thy1.2+ lympho-
cytes. The number of donor cells was calculated by 
multiplying the percentage CD8+Thy1.2+ cells in the 
FlowJo live gate by the percentage of live cells and by 
the number of lymphocytes calculated by the Coulter 
counter.
Intracellular cytokine staining
Single cell suspensions from various organs were cul-
tured in TCM with 11 μM HA peptide (W. Alton Jones 
Cell Science Center, Lake Placid, NY) overnight with 10 
μg/ml Brefeldin A (Sigma) added after the first 4 h. The 
cells were harvested and incubated with anti-IFN-γ-PE 
(XMG1.2) or anti-TNF-α-PE (MP6-XT22), both from BD 
Biosciences, in saponin buffer (0.1% saponin from Quil-
laja Bark, Sigma) in PBS [34]. The cells were then pro-
cessed as above for surface staining of Thy1.2 and CD8 
and analyzed by flow cytometry.
Virus titer
Mice injected with CD8+ T cells and influenza-infected 
were euthanized at various times postinfection by cervi-
cal dislocation. The lungs were removed, snap-frozen in 
liquid N2, and stored at −70°C. The lungs were thawed, 
homogenized, and the influenza titer determined using 
the Madine Darby Canine Kidney (MDCK) cell plaque 
assay as detailed previously [17]. Plaque-forming units 
(PFU) are expressed per lung.
Cytotoxicity assay
Single cell suspensions were prepared from mice adop-
tively transferred with CD8+ T cells and infected with 
influenza. B cells were depleted from spleen with anti-
B220 beads using MACS columns according to manufac-
turer’s instructions (Miltenyi Biotech). Lung cells were 
enriched for lymphocytes by centrifugation on Lympho-
lyte-poly (Cedarlane, Hornby, Canada) and then incu-
bated with anti-Thy1.2 beads. Thy1.2+ and Thy1.2− pop-
ulations were obtained from these cells using MACS 
columns (Miltenyi Biotech). 51Cr-labeled P815 cells (Per-
kin Elmer NEN, Boston, MA), 1 × 104, pulsed or un-
pulsed with HA peptide were incubated with Thy1.2+ or 
Thy1.2− lung cells, B cell-depleted splenocytes, DLN, or 
NDLN cell populations for 4 h as described previously 
[16]. Maximum lysis was determined by incubation with 
0.1% Triton X 100 (Sigma) and spontaneous lysis by in-
cubation in medium alone. The percentage lysis was cal-
culated by (experimental–spontaneous lysis/maximum 
lysis–spontaneous lysis) × 100. Spontaneous lysis of un-
pulsed P815 cells was <20% in all wells.
Results
The expansion and localization of adoptively transferred HA 
peptide-specific TCR transgenic naive CD8+ T cells vary be-
tween lymphoid and nonlymphoid sites
We first assessed the magnitude of the response of 
naive HA peptide-specific CD8+ TCR transgenic T 
cells to an influenza infection. Naive donor HA-spe-
cific CD8+ T cells were transferred into BALB/c mice 
subsequently infected 16–20 h later with PR8 influ-
enza. At various times postinfection, we analyzed sin-
gle cell suspensions from five tissues: DLN (medias-
tinal and parathymic lymph nodes), NDLN (axillary, 
brachial, and inguinal lymph nodes), spleen, airways 
[bronchoalveolar lavage (BAL)], and lung. The abso-
lute numbers of CD8+ donor cells detected in each set 
of tissues are shown on a logarithmic scale in Figure 
1A. The time of the peak CD8+ response was similar 
in DLN, spleen, BAL, and lung, 8 to 9 days postinfec-
tion (Figure 1A and data not shown). Significant popu-
lations of donor cells were found in the DLN at Day 4 
postinfection with no cells in lung and BAL at this time 
point. At Days 6 and 8 postinfection, high numbers of 
donor cells were found in lung and lower numbers in 
spleen and DLN. Numbers of donor cells declined in 
all organs by Day 29 postinfection with the exception 
of the NDLN. These data together indicated that the 
donor cell accumulation was focused near to the site of 
infection, the lung.
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To compare the extent of proliferation in various tis-
sues, we calculated the numbers of adoptively trans-
ferred CD8+ T cells recovered from mice sublethally in-
fected with influenza or mock-infected with PBS. To 
quantify the extent of the expansion of CD8+ T cells 
brought about by influenza infection, we divided the 
number of adoptively transferred cells recovered from 
infected mice by the number of adoptively transferred 
cells recovered from uninfected controls. The result is 
shown in Table 1. Large numbers of cells are generated 
early in the response in the draining lymph node, and 
the action moves later to the lung and then to the BAL.
Virus is cleared and weight loss is restored following the ap-
pearance of T cells in the lung and BAL
The presence of influenza virus in the lungs was mea-
sured using a plaque assay. Figure 1B shows that the vi-
ral titer in the lungs of mice after adoptive transfer of 
HA peptide-specific CD8+ T cells followed by influenza 
infection is high from Days 2 to 6 postinfection and then 
decreases. The peak of cell numbers in the lung and BAL 
therefore correlates with clearance of virus from the 
lungs. Figures 1B and C show that the weight loss and 
viral clearance did not significantly differ in mice that 
Figure 1. Adoptively transferred CD8+ TCR transgenic T cells expand and then decline after influenza virus infection and mice clear 
the virus with concurrent loss and gain of body weight. (A) Thy1.2+ CFSE-labeled naive clone-4 HA CD8+ transgenic T cells, 5 × 106, 
were adoptively transferred into Thy1.1+ syngeneic recipients infected intranasally 18 h later with 0.5 LD50 influenza. (A) Mice were 
sacrificed at indicated times, and the number of donor cells from draining lymph nodes (DLN), nondraining lymph nodes (NDLN), 
spleen, lung tissue, and brochoalveolar lavage (BAL) was determined by flow cytometry. Values shown are mean ± SD of three to 
six mice per group. These data are from a representative experiment repeated eight times with similar results. (B) Lung virus load 
(units shown are PFU per lung and dotted line indicates limit of detection) and (C) mouse weight with adoptive transfer of 7 × 105 
naive CD8+ T cells or PBS and 3000 EIU influenza infection. Results are from one representative experiment of three.
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did not receive donor cells, indicating that the adop-
tively transferred lymphocytes did not significantly 
accelerate viral clearance over the rate seen in the un-
treated host.
CFSE-labeled CD8+ T cells divided early during infection in 
the DLN and changed cell surface phenotype
The influenza-specific T cell precursor frequency is very 
high following the adoptive transfer of large numbers of 
antigen-specific cells allowing a detailed analysis of the 
early events that are below the level of detection using 
tetramer analysis. At Days 2 and 3 postinfection, all do-
nor cells retained high levels of CFSE in all organs ex-
amined (data not shown) indicating that division had 
not yet begun. As shown in Figure 2A, donor cells have 
already divided up to seven times in the DLN by Day 4 
postinfection; in contrast, low levels of cell division are 
seen in the spleen and no division in NDLN. The sur-
face expression levels of CD43, CD44, and CD25 in-
creased as the cells divided in the DLN but are still low 
in the spleen and NDLN at this time point. Adoptively 
transferred cells recovered from the DLN decrease cell 
surface expression of CD62L as the cells divide, but ex-
pression of this marker remains high on undivided cells 
recovered from NDLN and spleen. The Ly6C phenotype 
was low to intermediate in all tissues at Day 4. CD69 
cell surface expression is increased initially on cells re-
covered from the DLN and then decreases as the cells 
divide (data not shown). The cell division and gain of 
an activated phenotype are seen first in DLN, and cells 
with an activated phenotype are found in other lym-
phoid and nonlymphoid organs at later time points.
Adoptively transferred CD8+ HA peptide-specific T cells pos-
sess an activated phenotype at the peak of cell accumulation
Figure 2B shows that virtually all of the adoptively trans-
ferred CD8+ T cells have divided by Day 8, as measured 
by loss of CFSE, and have a progressively activated phe-
notype with gain of activation-associated markers in the 
DLN, NDLN, and spleen. The cells that enter the lung 
and BAL all have low CFSE intensity, indicating that 
more than seven divisions have occurred, and possess 
high surface expression of CD43, CD44, CD25, and Ly6C 
and low CD62L. The level of CD25 on the donor cells 
found in the DLN at Day 8 postinfection is lower than 
that seen at Day 4, but other activation markers (CD43 
and CD44) remain high at this time. The donor cells also 
expressed increased levels of CD54, CD11a, and CD49d 
upon activation (data not shown). In addition, the trans-
gene TCR Vβ is expressed at high levels during the re-
sponse, and there are a subset of cells present in the lung 
that express CCR5 (data not shown).
Table 1. Influenza infection leads to increased numbers of do-
nor lymphocytes in DLN, lung, and BAL compared with unin-
fected controls
Days                     Organ sampledb
postinfectiona       DLN       NDLN    Spleen    Lung           BAL
Day  4 47.11c  0.25  0.28  0.84  6.22
Day 7  322.51  0.27  13.7  1651  17.062
Day 11  90.95  0.002  0.71  620  58.752
a Days postinfection with influenza.
b Organs were taken from euthanized mice and donor cell 
numbers determined using flow cytometry.
c The ratio of numbers of cells recovered from mice given 5 × 
106 HA clone-4 naive transgenic T cells at Day –1, infected 
with influenza divided by mice given PBS intranasally. 
Numbers are the ratio of three infected animals per group 
divided by three uninfected animals. Representative exper-
iment repeated three times.
Figure 2. Adoptively transferred CD8+ T cells show division 
and gain of activation-associated molecules in the DLN at Day 
4 postinfection and possess a highly activated phenotype at 
Day 8 postinfluenza. Cells were transferred and mice infected 
with influenza as described in Figure 1. (A) Four and (B) eight 
days later, mice were euthanized. Cells from DLN, NDLN, 
spleen, lung tissue, and BAL were analyzed by flow cytome-
try. Profiles shown are gated for cells that are CD8+Thy1.2+. 
Results are one mouse in a group of three from a representa-
tive experiment repeated eight times with similar results.
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Adoptively transferred CD8+ cells can produce IFN-γ in re-
sponse to specific influenza peptide and are cytotoxic immedi-
ately ex vivo
Cytokine expression by donor CD8+ CFSE-labeled T 
cells was examined ex vivo by flow cytometric intra-
cellular cytokine staining to document the acquisition 
of effector function in the donor cells [35, 36]. IFN-γ ex-
pression by donor cells at Days 4 and 6 postinfection 
is shown in Figures 3A and B. Cells recovered at Day 
4 showed significant IFN-γ expression in DLN, mostly 
from divided cells, but there was some IFN-γ expression 
in spleen and NDLN. At Day 6, cells from all organs ex-
amined produced intracellular IFN-γ in response to pep-
tide, and the majority of these IFN-γ positive cells had 
divided many times (low CFSE intensity). The highly di-
vided cells are also capable of producing TNF-α at Days 
6 and 8 postinfection (data not shown).
To further characterize the effector function, we in-
vestigated whether donor cells were able to lyse peptide 
pulsed target cells in an ex vivo 4-h chromium release 
assay, isolated and tested without restimulation. As 
shown in Figure 3C, the immediate ex vivo HA peptide-
specific CTL activity is similar for donor cells recovered 
from the lungs and spleen where high amounts of cyto-
toxicity were found. Cells recovered from the DLN were 
less cytotoxic, and cells from NDLN were without ac-
tivity. Thus, the adoptively transferred CD8+ T cells de-
velop the surface phenotype and ex vivo function con-
sistent with highly activated influenza-specific effectors 
in the influenza-infected host.
Figure 3. Adoptively transferred CD8+ T cells are able to make IFN-γ upon restimulation and are immediately cytotoxic ex vivo. 
Thy1.2+ CFSE-labeled naive clone-4 HA CD8+ transgenic T cells were adoptively transferred into Thy1.1+ recipients followed 18 
h later by influenza infection. Mice were sacrificed 4 (A) or 6 (B) days postinfection, and cells from various organs were incubated 
with or without HA peptide overnight followed by intracellular cytokine staining. (C) Seven days postinfection, cytotoxicity of 
cells from various organs was tested in a 51Cr release assay. E:T ratios are calculated on the number of Thy1.2 donor cells in the 
sample. Results shown are one representative experiment of (A, B) three and (C) two.
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Adoptively transferred CD8+ T cells still present at Day 30 
postinfection are able to make cytokines upon restimulation 
in vitro
We had seen earlier that significant numbers of CD8+ 
lymphocytes persisted until at least Day 29 postinfection 
(Figure 1), and so the phenotype and CFSE intensity of 
these CD8 T cells were analyzed by flow cytometry as 
shown in Figure 4. The surface phenotype of these cells 
was significantly different from that seen during the ef-
fector phase. Resting CD8+ cells recovered from DLN, 
NDLN, and spleen expressed both high and low surface 
levels of CD62L, while CD8 T cells recovered from BAL 
and lung expressed low surface levels of CD62L. The 
cells in the lymphoid tissues had also decreased surface 
expression of CD43, but the majority of cells recovered 
from the lung maintained high surface expression of 
CD43. The expression of Ly6C was high to intermediate 
in lymphoid tissues and mixed medium and low in lung 
and BAL. The CD25 expression was low in all tissues ex-
amined, and CD44 remained high. The adoptively trans-
ferred CD8+ T cells persisting at Day 34 made IFN-γ and 
TNF-α when stimulated with HA peptide overnight, as 
shown in Figure 5. These cells resemble memory cells 
and produce cytokines after in vitro stimulation.
Cotransfer experiments showed that CD4+ T cells expanded 
less than CD8+ T cells and that the CD4+ T cells decline more 
rapidly
The numbers and accumulation kinetics we had found 
for CD8+ T cells differed from that previously found for 
CD4+ T cells [18]. It was therefore important to compare 
the recruitment and proliferation of adoptively trans-
ferred CD4+ and CD8+ T cells in the same animal to de-
termine whether there were significant differences dur-
ing influenza infection. We adoptively transferred 3 × 
106 CFSE-labeled naive CD4+ HNT T cells and 3 × 106 
CFSE-labeled naive CD8+ HA T cells into the same Thy-
1 disparate host and enumerated these cells in the five 
sets of tissues at various times after influenza infection.
Neither CD4+ nor CD8+ T cells were present in the 
lungs or BAL in significant numbers on Day 4 (Figure 
6A). At Day 7, both cell types appeared in the lung, and 
BAL and had downregulated CD62L surface expression 
(data not shown). The CD8+ donor cell numbers within 
the DLN were higher than that of CD4+ T cells, higher in 
the lung, and comparable in the spleen. The number of 
CD8+ T cells peaked 10-fold higher in the lung at Day 9, 
and the peak of the response was later than that seen for 
donor CD4+ cells. The subsequent decline of the CD4+ T 
cells was more pronounced than that of CD8+ T cells in 
the lung and BAL. In addition, there were many folds 
more CD8+ than CD4+ T cells in the lung and BAL at 
Day 30 postinfection, but more similar numbers of CD4+ 
and CD8+ T cells were seen in spleen, DLN, and NDLN. 
FACS profiles of CFSE-labeled donor cells recovered at 
Days 4 and 7 postinfection are shown in Figure 6B, dem-
onstrating that CD4+ and CD8+ T cells divide similarly 
in response to influenza infection. (In the figure, CD4+ T 
cells are scored as CD8−, but the same picture was seen 
when cells were stained with anti-CD4, and CD8+ cells 
were scored as CD4−, data not shown). Both adoptively 
transferred CD4+ and CD8+ cells gained surface expres-
sion of CD43 and lost surface expression of CD62L con-
currently with increasing number of divisions (data 
not shown). The cotransfer experiments confirmed that 
CD8+ T cells expanded more than CD4+ T cells, that the 
CD8+ T cell response was more prolonged, and that the 
higher number of CD8+ effectors at the peak was fol-
lowed by higher numbers of persisting memory cells at 
Day 30 postinfection.
Adoptive cotransfer of decreasing numbers of CD8+ and 
CD4+ T cells shows that smaller numbers of CD8+ T cells ex-
pand to a greater extent than small numbers of CD4+ T cells
We were concerned that the high numbers of cells used 
in the adoptive transfers might lead to artificially high 
numbers of cells recovered and inefficient activation. In 
other studies, we found that adoptive transfer of small 
numbers (102) and large numbers (107) of naive trans-
genic CD8+ T cells with peptide pulsed dendritic cells re-
sulted in similar numbers of antigen-specific cells recov-
ered at Day 7 after transfer (Kemp et al., unpublished). 
We concluded that it should be possible to follow the 
later stages of the response in the current studies using 
much lower number of naive donor cells and determine 
whether kinetics of accumulation between CD4+ and 
CD8+ T cells were still different beginning with a lower 
number of cells.
Figure 4. Adoptively transferred CD8+ lymphocytes possess 
a resting phenotype at Day 29 postinfection. Cells were trans-
ferred and mice infected with influenza as described in leg-
end to Figure 1. After 29 days, cells from DLN, NDLN, spleen, 
lung, and BAL were analyzed by flow cytometry. Results are 
one mouse in a group of three from a representative experi-
ment repeated eight times with similar results.
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We transferred varying numbers of CD4+ and CD8+ 
cells into the same animal and compared the numbers 
found in various organs after at different time points 
postinfection. As shown in Figure 7, we again found that 
the number of both CD4+ and CD8+ T cells recovered at 
later time points was not proportional to the numbers 
injected but converged towards the same peak level. The 
greater expansion and localization to the lung of CD8+ T 
cells than CD4+ were still apparent at the intermediate 
and lowest input dose. The overall kinetics of the two 
Figure 5. Adoptively transferred cells recovered at Day 34 postinfection are able to make IFN-γ and TNF-α upon in vitro stimulation. 
Cells were transferred and mice infected with influenza as described in legend to Figure 1. After 34 days, mice were sacrificed and 
cells from DLN, NDLN, spleen, lung, and BAL were incubated overnight followed by intracellular cytokine staining for (A) IFN-γ 
and (B) TNF-α. Results are one mouse in a group of two from a representative experiment repeated twice with similar results.
Figure 6. CD8+ T cells possess more prolonged expansion and reach higher numbers than CD4+ T cells, but division is similar af-
ter influenza infection. Thy1.2+ CFSE-labeled naive HNT CD4+ transgenic T cells, 3 × 106, and Thy1.2+ CFSE-labeled naive clone-4 
HA CD8+ transgenic T cells, 3 × 106, were adoptively transferred into Thy1.1+ recipients followed 18 h later by influenza infection. 
(A) Mice were sacrificed at indicated times and cells from DLN, NDLN, spleen, lung, and BAL were analyzed by flow cytometry 
and the number of cells in each organ calculated. Values shown are mean ± SD of three mice per group. (B) CFSE profiles versus 
CD8+ staining in donor cells isolated at Days 4 and 7 postinfection. These are representative data from one experiment repeated 
five times with similar results.
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responses are similar for the CD4+ and CD8+ T cell pop-
ulations. Therefore, we find that decreasing the numbers 
of adoptively transferred cells confirms the observation 
that CD8+ T cells reach a higher peak number than CD4+ 
T cells in the lung, and these increased numbers also oc-
cur with smaller numbers of input cells.
Discussion
We have shown here that adoptively transferred CFSE-
labeled HA peptide-specific TCR transgenic CD8+ T 
cells are found to have begun to divide first and produce 
IFN-γ in the DLN, then at later time points are detected 
in large numbers in the lung, BAL, and spleen in re-
sponse to influenza infection. Highly activated effectors 
recovered from the lung are able to kill peptide pulsed 
targets ex vivo and are able to produce cytokines upon 
in vitro restimulation. The surface phenotype of these 
cells differs in various tissues and changes as the cells 
divide. The expression of CD25, CD43, CD44, and sev-
eral other adhesion molecules becomes elevated, while 
the expression of CD62L declines. When the activation 
of CD4+ and CD8+ T cells in response to influenza were 
compared directly in the same mouse, both cell types 
were initially found in large numbers in the DLN and 
at later time points in the lung, BAL, and spleen. The 
gain of effector phenotype and CFSE-monitored cell di-
vision was similar in both CD4+ and CD8+ T cells. CD8+ 
T cells expanded to higher numbers than CD4+ T cells, 
and the decline in number of CD8+ T cells after the peak 
was more gradual. The number of recovered CD8+ and 
CD4+ T cells drops dramatically in all organs sampled 
after virus has been cleared, but a residual population of 
adoptively transferred memory cells is detectable until 
at least Day 30 postinfection.
Adoptively transferred influenza HA-specific CD8+ T 
cells in the DLN divide and express increasingly high lev-
els of CD25, CD43, and CD44 and lower levels of CD62L 
at 4 days postinfection. These changes are not seen in cells 
found in the spleen and NDLN at Day 4 suggesting that 
the HA-specific cells are initially activated in the draining 
lymph nodes which had been proposed before from cell 
accumulation data [21]. At later time points, the HA-spe-
cific cells possess an activated phenotype in all organs ex-
amined. The cells in the lung and BAL have higher levels 
of CD25 and CD43 and lower levels of CD62L correlat-
ing well with the higher cytotoxic activity of cells isolated 
from the lung. The different populations of cells in the 
two locations could represent different subsets of effec-
tors or cells at different activation states.
Figure 7. Titration of donor cells reveals similar dose-dependent kinetics between CD4+ and CD8+ T cell accumulation after influ-
enza infection in vivo. Graded numbers of (Thy1.1+ × Thy1.2+) F1 CD4+ and CD8+ T cells were mixed and adoptively transferred 
into Thy1.2+ recipients subsequently infected with influenza (6000 EIU). The number of donor Thy1.1+ CD8+ (A) or CD4+ (B) T 
cells was calculated from DLN, spleen, and lung. Values shown are mean ± SD of four mice per group. These data are from a rep-
resentative experiment repeated twice with similar results.
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Cell division is generally correlated with activation 
for both CD4+ and CD8+ T cells [6, 37, 38] but may not 
be the case with activation-induced tolerance [39]. We 
address this question directly using CFSE and surface 
activation markers and find that division correlates with 
activation in this infection (Figure 2 and Figure 3). Cy-
totoxic cells were recovered from the lungs and spleen, 
and these populations consisted an overwhelming ma-
jority of divided cells. Undivided cells express elevated 
levels of CD69 (data not shown) and can produce cy-
tokines upon restimulation in vitro (Figure 3), suggest-
ing that these cells are partially activated as recently re-
ported by others [38].
CD43 expression declines in the lymphoid tissues but 
remains high in the lung and BAL at Day 30 and high-
lights differences between lymphocytes persisting in the 
lungs/BAL and lymphoid tissues [40 and 41]. Previous 
studies had only shown CD43 decline in the spleen [42]. 
The Ly6C expression on naive cells consists both a pos-
itive and negative population, the significance of which 
is unclear [3]. Here, we show an increased surface level 
of Ly6C during influenza infection which is similar to 
anti-CD3 activation in vivo [43]. Ly6C remains high on 
memory CD8+ cells in peripheral lymphoid tissues and 
is mixed within the lung and BAL. Ly6C may play a role 
in the trafficking of CD8+ lymphocytes [44], but the sig-
nificance of the biphasic level of expression in the lung 
is not clear but could indicate differential function or 
migration ability.
The adoptively transferred CD8 T cells develop effec-
tor function, but this differs in cells from different loca-
tions. We found high levels of ex vivo CTL activity in 
cells from the lung and spleen, but little or no activity 
in cells from the DLN and NDLN. CTL activity in cells 
from the influenza-infected lung has been reported pre-
viously [13, 33]. This lack of CTL activity in DLN agrees 
with Johnson et al. [45], but they also found low CTL ac-
tivity in the spleen. The higher numbers of CTL in the 
spleen after adoptive transfer and infection may re-
flect higher numbers of activated cells accumulating or 
that the adoptively transferred cells have better access 
to antigen and therefore are more highly activated. The 
adoptively transferred cells are able to make IFN-γ and 
TNF-α, as previously found using tetramers to identify 
influenza-specific CD8+ T cells [7]. Our data indicate 
that IFN-γ is acquired early in the response before cells 
have divided showing that IFN-γ is switched on earlier 
than previously appreciated.
Recent suggestions have been made that CD8+ T cells 
proliferate more rapidly than CD4+ T cells [2, 27, 28]. In 
our experiments, we followed the expansion of CFSE-la-
beled CD4+ T cells and CD8+ T cells in the same mouse. 
Our data are in agreement with that found by Homann 
et. al. [27] who reported that CD4+ and CD8+ T cells ex-
panded to a peak at a similar rate, but the number of 
CD4+ cells decline more rapidly after the peak. We have 
also confirmed the same difference between the two cell 
types, using very much lower initial number of CD4+ or 
CD8+ T cells demonstrating that both cell types were ca-
pable of perhaps 10000-fold expansion, but total num-
bers were lower for CD4+ T cells than CD8+ T cells in-
dicating that these two populations were regulated 
differentially after the first five to six divisions. The cells 
that persist 30 days after adoptive transfer express low 
levels of CD25 indicating resting memory cells [3]. The 
higher numbers of CD8+ than CD4+ we see at Day 30 
are in agreement with recent studies that suggest that 
CD8+ T cells are more stable as memory cells than CD4+ 
T cells after respiratory infection [46]. The mechanism of 
differential survival of CD4+ and CD8+ T cells after in-
fluenza infection is unclear but could be due to differen-
tial expression of Bcl2 as proposed for LCMV [27]. Other 
mechanisms could be that the cells are responding to dif-
ferent costimulatory signals such as OX40 [47] or CD27 
[48] or different amounts of persisting antigen presented 
by MHC class I or II molecules [49]. The TCR transgenic 
cells may not reflect all populations of antigen-specific 
cells because immunodominance and antigen affinity 
may affect the relative kinetics of the two populations 
[50, 51]. Examination of host CD8+ and CD4+ T cell re-
sponses to influenza infection indicates that the CD8+ 
T cells predominate in the lungs as seen with the adop-
tive transfer studies (data not shown). Also, these data 
shown here agree with studies analyzing antigen-spe-
cific CD4+ and CD8+ T cells after Sendai virus infection 
[46].
In summary, we have described an adoptive transfer 
system that allows the visualization of both the early and 
late stages of antigen-specific CD4+ and CD8+ T cell re-
sponse during influenza infection in the same recipient. 
We have been able to demonstrate the relative kinetics of 
an antigen-specific population of both CD4+ and CD8+ 
T cells responding to influenza infection. The pheno-
typic changes that occur and localization of the cells into 
the lung and BAL are similar for both CD4+ and CD8+ 
T cells. Both CD4+ and CD8+ immune responses to in-
fluenza appear to be initiated in draining lymph nodes. 
The responding cells undergo similar changes in the ex-
pression of cell surface markers. The CD4+ and CD8+ T 
cells appear to divide at a similar rate, but CD8+ T cells 
increase to 10-fold more than CD4+ T cells. The CD8+ T 
cells continue to expand after the CD4+ T cells peak and 
then decline in numbers more slowly than CD4+ T cells. 
Thus, CD4+ and CD8+ T cells are regulated differentially 
to perform distinct functions, and this adoptive transfer 
system is ideal to investigate these responses.
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